These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4057906)

  • 1. [A beta ray applicator (106Ru/106Rh) in the treatment of ciliary body melanomas].
    Ballin R; Lommatzsch PK; Drost H; Ratajek B
    Klin Monbl Augenheilkd; 1985 Aug; 187(2):144-6. PubMed ID: 4057906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The potential for organ-preserving treatment in large uveal melanoma].
    Terent'eva LS; Fokin VP
    Oftalmol Zh; 1989; (6):338-41. PubMed ID: 2622597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
    Lommatzsch PK
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):428-9. PubMed ID: 274003
    [No Abstract]   [Full Text] [Related]  

  • 4. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
    Busse H; Müller RP
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of ciliary body melanoma by beta radiation.
    Foerster MH; Wessing A; Meyer-Schwickerath G
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():64-7. PubMed ID: 6581638
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
    Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
    Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation retinopathy following treatment of choroid melanomas with 106Ru/106Rh applicators].
    Foerster MH; Fried M; Wessing A; Meyer-Schwickerath G
    Fortschr Ophthalmol; 1983; 80(5):418-21. PubMed ID: 6642368
    [No Abstract]   [Full Text] [Related]  

  • 8. Experiences in the treatment of malignant melanoma of the choroid with 106Ru-106Rh beta-ray applicators.
    Lommatzsch PK
    Trans Ophthalmol Soc U K (1962); 1973; 93(0):119-32. PubMed ID: 4526435
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiation therapy for uveal melanomas involving the ciliary body.
    Char DH
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 2)():252-6. PubMed ID: 3467500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impression cytology of the conjunctiva following high-dose brachytherapy of malignant melanoma of the uvea using 106Ru/106Rh applicators].
    Koch JM; Bornfeld N; Waubke TN; Wessing A
    Fortschr Ophthalmol; 1988; 85(6):642-5. PubMed ID: 3220378
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of malignant melanomas of the uvea with 106-ruthenium applicators. Report on the first 100 Essen cases].
    Foerster MH; Bornfeld N; Wessing A; Schulz U; Schmitt G; Meyer-Schwickerath G
    Klin Monbl Augenheilkd; 1984 Dec; 185(6):490-4. PubMed ID: 6527503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical quality assurance for 106Ru ophthalmic applicators.
    Kaulich TW; Zurheide J; Haug T; Nüsslin F; Bamberg M
    Radiother Oncol; 2005 Jul; 76(1):86-92. PubMed ID: 15972240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)].
    Lommatzsch PK; Weise B; Ballin R
    Klin Monbl Augenheilkd; 1986 Aug; 189(2):133-40. PubMed ID: 3761990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques.
    Schilling H; Sehu KW; Lee WR
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2081-92. PubMed ID: 9331272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
    Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
    Lommatzsch P
    Surv Ophthalmol; 1974; 19(2):85-100. PubMed ID: 4612808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Echocardiography findings before and following beta-irradiation (106Ru/106Rh) of choroid melanoma].
    Eichler C; Hertel A; Lommatzsch PK; Fuhrmann P
    Klin Monbl Augenheilkd; 1987 Jan; 190(1):17-20. PubMed ID: 3573649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Irradiation of retinoblastoma with 106Ru/106Rh applicators.
    Lommatzsch P
    Mod Probl Ophthalmol; 1977; 18():128-36. PubMed ID: 876042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
    Razzaq L; de Keizer RJ
    Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
    [No Abstract]   [Full Text] [Related]  

  • 20. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years' experience.
    Lommatzsch PK
    Am J Clin Oncol; 1987 Apr; 10(2):146-51. PubMed ID: 3565313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.